4 Patient Assistance Programs (PAPs) for Eltrombopag Patients in Need
.png)
Eltrombopag is a medication used to treat thrombocytopenia (low platelets in the blood) in patients with conditions such as chronic immune thrombocytopenia (ITP) and thrombocytopenia associated with hepatitis C virus (HCV) infections. The cost of Eltrombopag can be a significant burden for many patients. This blog provides information on financial assistance programs that can help eligible individuals afford this medication. Understanding the Cost of Eltrombopag The Eltrombopag price can be substantial, and the actual cost varies depending on dosage, location, and insurance coverage. The cost of 50 mg can be a significant burden for many patients, especially those requiring long-term treatment. For those without adequate insurance or who meet certain income requirements, several financial assistance programs can help. Patient Assistance Programs (PAPs) for Eltrombopag Patient Assistance Programs (PAPs) are sponsored by pharmaceutical companies and other or...